-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, NWZds418PaFomFCz/0HehMCNdl2SWGMsCAwTGeOSBL/SN3bvq1MSptnJqa7Rd0wU gXzOLFzV0i+rG4LMrXvPzQ== 0001218813-04-000001.txt : 20040213 0001218813-04-000001.hdr.sgml : 20040213 20040213123415 ACCESSION NUMBER: 0001218813-04-000001 CONFORMED SUBMISSION TYPE: 5 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20031231 FILED AS OF DATE: 20040213 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SAVIENT PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000722104 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 133033811 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 BUSINESS PHONE: 7324189300 MAIL ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 FORMER COMPANY: FORMER CONFORMED NAME: BIO TECHNOLOGY GENERAL CORP DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SHAW ROBERT M CENTRAL INDEX KEY: 0001218813 FILING VALUES: FORM TYPE: 5 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15313 FILM NUMBER: 04596433 MAIL ADDRESS: STREET 1: C/O BIOTECHNOLOGY GENERAL CORP STREET 2: ONE TOWER CENTER BLVD 14TH FLR CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 5 1 edgar.xml PRIMARY DOCUMENT X0201 5 2003-12-31 1 0 0 0000722104 SAVIENT PHARMACEUTICALS INC SVNT 0001218813 SHAW ROBERT M ONE TOWER CENTER BLVD., 14TH FLOOR EAST BRUNSWICK NJ 08816 0 1 0 0 Former Officer - EVP Common Stock, $.01 par value per share 2003-02-01 5 A 0 2292 2.1335 A 9014 D Common Stock, $.01 par value per share 2003-05-01 5 A 0 1146 2.1335 A 10160 D Common Stock, $.01 par value per share 2003-08-01 5 A 0 1146 2.1335 A 11306 D Common Stock, $.01 par value per share 2003-11-01 5 A 0 1145 2.1335 A 12451 D Consists of shares acquired pursuant to the Savient Pharmaceuticals, Inc. 1998 Employee Stock Purchase Plan, which were not previously reported on a Form 4. Robert M. Shaw 2004-02-13 -----END PRIVACY-ENHANCED MESSAGE-----